About Next Biomedical Co., Ltd.
Next Biomedical Co., Ltd. is a South Korean company specializing in the research, development, and production of innovative therapeutics, drug delivery systems, and drug-medical device products.
Key Offerings
- Hemostatic Material for Endoscope: Designed to support medical procedures requiring effective bleeding control.
- Microspheres for Vascular Embolization: Advanced solutions for targeted vascular treatments.
Company Background
Founded in 2014, Next Biomedical is headquartered in Incheon, South Korea, and is committed to advancing medical technology through cutting-edge research and development.